TruNorth Capital Management’s Chemours CC Stock Holding History

TruNorth Capital Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-30	Closed	-$610	–	389
2024 Q3	$610	Hold	30	–	–	﹤0.01%	376
2024 Q2	$677	Buy	+30	New	+$786	﹤0.01%	332

Other funds holding CC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TruNorth Capital Management's CC Position: Q4 2024 in Review

TruNorth Capital Management sold out of Chemours (CC) in Q4 2024, closing a stake of 30 shares — an estimated $610 sold.

TruNorth Capital Management first reported a position in CC in Q2 2024 and held it in 2 quarters. The position peaked at $677 in Q2 2024. 442 funds tracked by Wall St. Rank hold CC as of Q4 2024.

TruNorth Capital Management reported no remaining Chemours position as of Q4 2024 after selling out during the quarter.
TruNorth Capital Management sold 30 Chemours shares in Q4 2024, an estimated $610.
TruNorth Capital Management first reported a position in Chemours in Q2 2024 and held it in 2 quarters.
TruNorth Capital Management's Chemours position peaked at $677 in Q2 2024.
442 funds tracked by Wall St. Rank held Chemours as of Q4 2024.

Based on TruNorth Capital Management's 13F filing for Q4 2024, filed 4 Feb 2025.